Dosage and administration
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
Chelidonium majus 3X, Echinacea (Angustifolia) 3X, Hydrastis canadensis 3X, Nasturtium aquaticum 3X, Taraxacum officinale 3X, Rhus toxicodendron 5X, 12X, Arnica montana 6X, Glandula suprarenalis suis 6X, Medulla ossis suis 6X, Thymus (Suis) 6X, Oxalicum acidum 6X, 12X, Magnesia phosphorica 8X, Latrodectus mactans 8X, 12X, Borrelia burgdorferi nosode 12X, 30X, 200X, Encephalitis nosode 12X, 30X, 200X, Meningococcus nosode 15X, 30X, 200X, Hepatitis B nosode 30X, 200X.
For temporary relief of aches, pains and fatigue associated with Lyme disease.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
If pregnant or breast-feeding, ask a health professional before use.
Do not use if tamper evident seal is broken or missing.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
For temporary relief of aches, pains and fatigue associated with Lyme disease.
Demineralized Water, 25% Ethanol
Distributed by:
SYNERGY FORMULAS, INC.
251 West Road
Campobello, SC 29322
Synergy Formulas
LYMESODE
HOMEOPATHIC
2 FL OZ (60 ml)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43772-0021-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f7a5-f424-e053-dadaa90a57ce | Drug Facts: |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43772-0021-1 | Lymesode | 60 mL in 1 BOTTLE, DROPPER | LIQUID | 60 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43772-0021 | LYMESODE (CHELIDONIUM MAJUS, ECHINACEA (ANGUSTIFOLIA), HYDRASTIS CANADENSIS, NASTURTIUM AQUATICUM, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, RHUS TOXICODENDRON, ARNICA MONTANA,) LIQUID [SYNERGY FORMULAS, INC.] | 1 | Legacy NDC, 1 package rows | 20140728_1c48c08e-e4a3-4238-a71d-80c799ec1236.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ARNICA MONTANA | ACTIVE INGREDIENT | O80TY208ZW | 1 | |
| BORRELIA BURGDORFERI | ACTIVE INGREDIENT | 0J8NV9V5Q8 | 1 | |
| CHELIDONIUM MAJUS | ACTIVE INGREDIENT | 7E889U5RNN | 1 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE INGREDIENT | VB06AV5US8 | 1 | |
| GOLDENSEAL | ACTIVE INGREDIENT | ZW3Z11D0JV | 1 | |
| HEPATITIS B VIRUS | ACTIVE INGREDIENT | 77H9EM77P7 | 1 | |
| JAPANESE ENCEPHALITIS VIRUS | ACTIVE INGREDIENT | P07E7XWU9D | 1 | |
| LATRODECTUS MACTANS | ACTIVE INGREDIENT | XJJ7QA858R | 1 | |
| MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | ACTIVE INGREDIENT | HF539G9L3Q | 1 | |
| NASTURTIUM AQUATICUM | ACTIVE INGREDIENT | YH89GMV676 | 1 | |
| NEISSERIA MENINGITIDIS | ACTIVE INGREDIENT | V3TP2MD7F3 | 1 | |
| OXALIC ACID | ACTIVE INGREDIENT | 9E7R5L6H31 | 1 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE INGREDIENT | 398IYQ16YV | 1 | |
| SUS SCROFA BONE MARROW | ACTIVE INGREDIENT | VP2CN2G7Y8 | 1 | |
| SUS SCROFA THYMUS | ACTIVE INGREDIENT | 7B69B0BD62 | 1 | |
| TARAXACUM OFFICINALE | ACTIVE INGREDIENT | 39981FM375 | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE INGREDIENT | 6IO182RP7A | 1 | |
| TRIFOLIUM PRATENSE FLOWER | ACTIVE INGREDIENT | 4JS0838828 | 1 | |
| ARNICA MONTANA | ACTIVE MOIETY | O80TY208ZW | 1 | |
| BORRELIA BURGDORFERI | ACTIVE MOIETY | 0J8NV9V5Q8 | 1 | |
| CHELIDONIUM MAJUS | ACTIVE MOIETY | 7E889U5RNN | 1 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE MOIETY | VB06AV5US8 | 1 | |
| GOLDENSEAL | ACTIVE MOIETY | ZW3Z11D0JV | 1 | |
| HEPATITIS B VIRUS | ACTIVE MOIETY | 77H9EM77P7 | 1 | |
| JAPANESE ENCEPHALITIS VIRUS | ACTIVE MOIETY | P07E7XWU9D | 1 | |
| LATRODECTUS MACTANS | ACTIVE MOIETY | XJJ7QA858R | 1 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| NASTURTIUM AQUATICUM | ACTIVE MOIETY | YH89GMV676 | 1 | |
| NEISSERIA MENINGITIDIS | ACTIVE MOIETY | V3TP2MD7F3 | 1 | |
| OXALIC ACID | ACTIVE MOIETY | 9E7R5L6H31 | 1 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE MOIETY | 398IYQ16YV | 1 | |
| SUS SCROFA BONE MARROW | ACTIVE MOIETY | VP2CN2G7Y8 | 1 | |
| SUS SCROFA THYMUS | ACTIVE MOIETY | 7B69B0BD62 | 1 | |
| TARAXACUM OFFICINALE | ACTIVE MOIETY | 39981FM375 | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE MOIETY | 6IO182RP7A | 1 | |
| TRIFOLIUM PRATENSE FLOWER | ACTIVE MOIETY | 4JS0838828 | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43772-0021 | 43772-0021-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8a825f9d-8892-45bb-b404-8537ccb0bbae | 1c48c08e-e4a3-4238-a71d-80c799ec1236 | 2014-06-23 | Warnings | 8a825f9d-8892-45bb-b404-8537ccb0bbae 1c48c08e-e4a3-4238-a71d-80c799ec1236 |
Adverse event summaries are temporarily unavailable. Other product information remains available.